AVTX
Avalo TherapeuticsยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
AVTX Profile
Avalo Therapeutics, Inc.
A biopharmaceutical company that developing treatments for rare and orphan diseases
1500 Liberty Ridge Drive, Suite 321, Wayne, Pennsylvania 19087
--
Avalo Therapeutics, Inc., was incorporated in Delaware on January 31, 2011. The Company is a biopharmaceutical company that discovers, develops and commercializes targeted therapies for patients with needs in immunology, immuno-oncology and rare genetic diseases. The company has built a diverse portfolio of innovative therapies that deliver meaningful medical impact to patients in dire need. The company's clinical drug candidates often have proven mechanical principles, biomarkers or established proof-of-concept to expedite and increase the likelihood of success.
